| Bioactivity | Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome. |
| Invitro | Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome[1]. |
| Name | Neuromuscular Disorder-Targeting Compound 1 |
| CAS | 374538-23-5 |
| Formula | C15H25N3S |
| Molar Mass | 279.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robertson, David W., et al. TREATMENT OF FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME. WO 2001087308 A1. |
Neuromuscular Disorder-Targeting Compound 1
CAS: 374538-23-5 F: C15H25N3S W: 279.44
Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibro
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.